Literature DB >> 31566426

Progression of diabetic kidney disease in T2DN rats.

Oleg Palygin1,2, Denisha Spires1, Vladislav Levchenko1, Ruslan Bohovyk1, Mykhailo Fedoriuk1, Christine A Klemens1,2, Olga Sykes1, John D Bukowy1, Allen W Cowley1, Jozef Lazar1, Daria V Ilatovskaya1, Alexander Staruschenko1,2,3.   

Abstract

Diabetic kidney disease (DKD) is one of the leading pathological causes of decreased renal function and progression to end-stage kidney failure. To explore and characterize age-related changes in DKD and associated glomerular damage, we used a rat model of type 2 diabetic nephropathy (T2DN) at 12 wk and older than 48 wk. We compared their disease progression with control nondiabetic Wistar and diabetic Goto-Kakizaki (GK) rats. During the early stages of DKD, T2DN and GK animals revealed significant increases in blood glucose and kidney-to-body weight ratio. Both diabetic groups had significantly altered renin-angiotensin-aldosterone system function. Thereafter, during the later stages of disease progression, T2DN rats demonstrated a remarkable increase in renal damage compared with GK and Wistar rats, as indicated by renal hypertrophy, polyuria accompanied by a decrease in urine osmolarity, high cholesterol, a significant prevalence of medullary protein casts, and severe forms of glomerular injury. Urinary nephrin shedding indicated loss of the glomerular slit diaphragm, which also correlates with the dramatic elevation in albuminuria and loss of podocin staining in aged T2DN rats. Furthermore, we used scanning ion microscopy topographical analyses to detect and quantify the pathological remodeling in podocyte foot projections of isolated glomeruli from T2DN animals. In summary, T2DN rats developed renal and physiological abnormalities similar to clinical observations in human patients with DKD, including progressive glomerular damage and a significant decrease in renin-angiotensin-aldosterone system plasma levels, indicating these rats are an excellent model for studying the progression of renal damage in type 2 DKD.

Entities:  

Keywords:  diabetic glomerular disease; diabetic nephropathy; podocyte pathology; renin-angiotensin-aldosterone system; scanning ion microscopy; type 2 diabetic nephropathy

Mesh:

Substances:

Year:  2019        PMID: 31566426      PMCID: PMC6960784          DOI: 10.1152/ajprenal.00246.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  55 in total

1.  Region-Based Convolutional Neural Nets for Localization of Glomeruli in Trichrome-Stained Whole Kidney Sections.

Authors:  John D Bukowy; Alex Dayton; Dustin Cloutier; Anna D Manis; Alexander Staruschenko; Julian H Lombard; Leah C Solberg Woods; Daniel A Beard; Allen W Cowley
Journal:  J Am Soc Nephrol       Date:  2018-06-19       Impact factor: 10.121

2.  Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.

Authors:  Anthony H Barnett; Ambrish Mithal; Jenny Manassie; Russell Jones; Henning Rattunde; Hans J Woerle; Uli C Broedl
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01-24       Impact factor: 32.069

3.  Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.

Authors:  Piero Ruggenenti; Matias Trillini; Drazenka P Barlovic; Monica Cortinovis; Antonio Pisani; Aneliya Parvanova; Ilian P Iliev; Barbara Ruggiero; Stefano Rota; Maria C Aparicio; Annalisa Perna; Francesco Peraro; Olimpia Diadei; Flavio Gaspari; Fabiola Carrara; Nadia Stucchi; Davide Martinetti; Andrej Janez; Nadan Gregoric; Eleonora Riccio; Antonio C Bossi; Roberto Trevisan; Paolo Manunta; Giovanni Battaglia; Salvatore David; Filippo Aucella; Antonio Belviso; Andrea Satta; Giuseppe Remuzzi
Journal:  Diabetes Obes Metab       Date:  2019-02-22       Impact factor: 6.577

4.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

5.  Effects of genetic obesity on renal structure and function in the Zucker rat.

Authors:  B L Kasiske; M P Cleary; M P O'Donnell; W F Keane
Journal:  J Lab Clin Med       Date:  1985-11

6.  Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

7.  Nanoscale live-cell imaging using hopping probe ion conductance microscopy.

Authors:  Pavel Novak; Chao Li; Andrew I Shevchuk; Ruben Stepanyan; Matthew Caldwell; Simon Hughes; Trevor G Smart; Julia Gorelik; Victor P Ostanin; Max J Lab; Guy W J Moss; Gregory I Frolenkov; David Klenerman; Yuri E Korchev
Journal:  Nat Methods       Date:  2009-03-01       Impact factor: 28.547

8.  Initial characterization of a rat model of diabetic nephropathy.

Authors:  Marcelo A Nobrega; Stewart Fleming; Richard J Roman; Masahide Shiozawa; Nancy Schlick; Jozef Lazar; Howard J Jacob
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

Review 9.  Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.

Authors:  Suetonia C Palmer; Dimitris Mavridis; Eliano Navarese; Jonathan C Craig; Marcello Tonelli; Georgia Salanti; Natasha Wiebe; Marinella Ruospo; David C Wheeler; Giovanni F M Strippoli
Journal:  Lancet       Date:  2015-05-23       Impact factor: 79.321

Review 10.  Renal Biopsy in Type 2 Diabetic Patients.

Authors:  Eugenia Espinel; Irene Agraz; Meritxell Ibernon; Natalia Ramos; Joan Fort; Daniel Serón
Journal:  J Clin Med       Date:  2015-05-18       Impact factor: 4.241

View more
  19 in total

Review 1.  Using Genetic and Species Diversity to Tackle Kidney Disease.

Authors:  Michael R Garrett; Ron Korstanje
Journal:  Trends Genet       Date:  2020-04-30       Impact factor: 11.639

2.  Comprehensive assessment of mitochondrial respiratory function in freshly isolated nephron segments.

Authors:  Allison McCrimmon; Mark Domondon; Regina F Sultanova; Daria V Ilatovskaya; Krisztian Stadler
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-30

3.  Renal tubule ectopic lipid deposition in diabetic kidney disease rat model and in vitro mechanism of leptin intervention.

Authors:  Shasha Liu; Jingjing Da; Jiali Yu; Rong Dong; Jing Yuan; Fuxun Yu; Yan Zha
Journal:  J Physiol Biochem       Date:  2022-02-22       Impact factor: 4.158

4.  Behavioral, metabolic, and renal outcomes of 1-month isolation in adolescent male Dahl salt-sensitive rats.

Authors:  Oksana Nikolaienko; Elena Isaeva; Vladislav Levchenko; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-14       Impact factor: 3.619

5.  Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes.

Authors:  Alexey Shalygin; Leonid S Shuyskiy; Ruslan Bohovyk; Oleg Palygin; Alexander Staruschenko; Elena Kaznacheyeva
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Kidney physiology: our future is now.

Authors:  Heddwen L Brooks
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-19

7.  Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats.

Authors:  Denisha R Spires; Oleg Palygin; Vladislav Levchenko; Elena Isaeva; Christine A Klemens; Sherif Khedr; Oksana Nikolaienko; Alison Kriegel; Xi Cheng; Ji-Youn Yeo; Bina Joe; Alexander Staruschenko
Journal:  Physiol Genomics       Date:  2021-04-19       Impact factor: 4.297

8.  Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys.

Authors:  Oleg Palygin; Christine A Klemens; Elena Isaeva; Vladislav Levchenko; Denisha R Spires; Lashodya V Dissanayake; Oksana Nikolaienko; Daria V Ilatovskaya; Alexander Staruschenko
Journal:  iScience       Date:  2021-05-11

9.  Loss of Chloride Channel 6 (CLC-6) Affects Vascular Smooth Muscle Contractility and Arterial Stiffness via Alterations to Golgi Calcium Stores.

Authors:  Christine A Klemens; Evgeny G Chulkov; Jing Wu; Md Abdul Hye Khan; Vladislav Levchenko; Michael J Flister; John D Imig; Alison J Kriegel; Oleg Palygin; Alexander Staruschenko
Journal:  Hypertension       Date:  2021-01-04       Impact factor: 9.897

Review 10.  The Role of CXCL12 in Kidney Diseases: A Friend or Foe?

Authors:  Anni Song; Anni Jiang; Wei Xiong; Chun Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.